Skip to main content
Updating results

Regulator

  • Updated

Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment.

Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News